Two Sigma Advisers’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Two Sigma Advisers’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-650	Closed	-$59K	–	2951
2022 Q1	$59K	Sell	650 -1,110	-63%	-$113K	﹤0.01%	2568
2021 Q4	$181K	Buy	+1,760	New	+$250K	﹤0.01%	2307

Other funds holding UTRS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Two Sigma Advisers's UTRS Position: Q2 2022 in Review

Two Sigma Advisers sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q2 2022, closing a stake of 650 shares — an estimated $59K sold.

Two Sigma Advisers first reported a position in UTRS in Q4 2021 and held it in 2 quarters. The position peaked at $181K in Q4 2021. 20 funds tracked by Wall St. Rank hold UTRS as of Q2 2022.

Two Sigma Advisers reported no remaining Minerva Surgical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 650 Minerva Surgical, Inc. Common Stock shares in Q2 2022, an estimated $59K.
Two Sigma Advisers first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Two Sigma Advisers's Minerva Surgical, Inc. Common Stock position peaked at $181K in Q4 2021.
20 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.